A detailed history of Jane Street Group, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 13,216 shares of ABEO stock, worth $75,331. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,216
Holding current value
$75,331
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.12 - $6.32 $54,449 - $83,525
13,216 New
13,216 $83,000
Q1 2024

May 15, 2024

BUY
$4.07 - $8.68 $96,149 - $205,056
23,624 Added 57.78%
64,511 $467,000
Q4 2023

Feb 14, 2024

BUY
$3.71 - $5.14 $151,690 - $210,159
40,887 New
40,887 $204,000
Q4 2022

Feb 14, 2023

BUY
$2.4 - $5.65 $89,762 - $211,315
37,401 New
37,401 $115,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $33.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.